Demographic and clinical characteristics of depot medroxyprogesterone acetate and intrauterine device groups at baseline
| Characteristic | Total (N=234) | DMPA (N=116) | IUD (N=118) | p |
|---|---|---|---|---|
| Age [median (IQR)] | 26 (11–23) | 26 (10–22) | 26.5 (11–22) | |
| Smoker [n (%)] | 4 (1.7) | 3 (2.5) | 1 (0.8) | 0.37 |
| Diabetes [n (%)] | 2 (0.8) | 0 | 2 (1.6) | 0.50 |
| Hypertension [n (%)] | 16 (6.3) | 8 (6.7) | 8 (6.7) | 0.97 |
| HIV-positive [n (%)] | 91 (39.0) | 39 (33.0) | 52 (44.0) | 0.10 |
| CD4 count [mean (SD)] | 385 (177) (n=86) | 438 (173) (n=37) | 344 (170) (n=49) | 0.01* |
| Previous PID [n (%)] | 5 (2.1) | 2 (1.7) | 3 (2.5) | 0.98 |
| Unplanned pregnancy [n (%)] | 181 (77.0) | 97 (83.0) | 84 (71.0) | 0.35 |
| Previous contraception [n (%)] | ||||
| Injectable | 204 (87.0) | 100 (86.0) | 104 (88.0) | 0.66 |
| Pill | 20 (8.5) | 10 (8.2) | 10 (8.2) | 0.97 |
| IUD | 0 | 0 | 0 | |
| Condom use [n (%)] | 164 (70.0) | 78 (67.0) | 86 (72.0) | 0.35 |
| Married [n (%)] | 49 (20.0) | 21 (18.0) | 28 (23.0) | 0.33 |
| Employment status [n (%)] | ||||
| Employed | 61 (26.0) | 34 (31.0) | 27 (22.0) | 0.27 |
| Student | 37 (15.0) | 21 (18.0) | 16 (13.0) | 0.34 |
| Seeking work | 63 (26.0) | 28 (24.0) | 35 (29.0) | 0.34 |
| Education [n (%)] | ||||
| Primary (minimum) | 178 (76.0) | 85 (73.0) | 93 (78.0) | 0.32 |
| Degree or diploma | 16 (6.8) | 8 (7.0) | 8 (7.0) | 0.97 |
*Significant difference p<0.05.
DMPA, depot medroxyprogesterone acetate; HIV, human immunodeficiency virus; IUD, intrauterine device; PID, pelvic inflammatory disease; SD, standard deviation.